KindlyMD, Inc. (NASDAQ:NAKA) Stock Has Average Price Target of $20.00 According to Analysts

KindlyMD, Inc. (NASDAQ:NAKA) has received a consensus rating of “Hold” from the five analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating on the company. The average 12-month target price among brokers that have covered the stock in the last year is $20.00.

A number of brokerages have issued reports on NAKA. B. Riley Financial lifted their price objective on KindlyMD from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Tuesday, September 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of KindlyMD in a report on Friday, August 7th. Finally, TD Cowen lifted their price target on KindlyMD from $1.00 to $17.00 and gave the stock a “buy” rating in a research report on Monday, July 27th.

Insider Transactions at KindlyMD

In other news, CEO David F. Bailey bought 32,134 shares of the company’s stock in a transaction dated Wednesday, August 19th. The shares were purchased at an average price of $5.59 per share, for a total transaction of $179,629.06. Following the completion of the purchase, the chief executive officer owned 32,134 shares in the company, valued at approximately $179,629.06. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders have bought 41,904 shares of company stock valued at $235,231 over the last three months. 24.49% of the stock is currently owned by insiders.

Institutional Investors Weigh In On KindlyMD

Several institutional investors and hedge funds have recently made changes to their positions in the company. J. Derek Lewis & Associates Inc. bought a new position in KindlyMD in the 4th quarter valued at approximately $167,000. Waddell & Associates LLC bought a new stake in shares of KindlyMD in the 4th quarter worth $201,000. Arrington Capital Management LLC purchased a new position in shares of KindlyMD in the fourth quarter worth $1,028,000. Yorkville Advisors Global LP purchased a new position in shares of KindlyMD in the fourth quarter worth $3,265,000. Finally, Hunting Hill Global Capital LLC bought a new position in shares of KindlyMD during the fourth quarter valued at $4,672,000.

KindlyMD Stock Performance

Shares of NASDAQ NAKA opened at $8.93 on Friday. The company has a 50 day simple moving average of $7.51 and a two-hundred day simple moving average of $6.71. KindlyMD has a fifty-two week low of $3.33 and a fifty-two week high of $42.00. The company has a market capitalization of $159.85 million, a price-to-earnings ratio of -0.25 and a beta of 15.82.

KindlyMD (NASDAQ:NAKA) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($6.65) EPS for the quarter. The company had revenue of $35.87 million during the quarter. KindlyMD had a negative return on equity of 63.45% and a negative net margin of 1,067.93%. On average, analysts forecast that KindlyMD will post -12.94 earnings per share for the current fiscal year.

About KindlyMD

KindlyMD is a healthcare company focused on providing integrated, patient-centered medical services. Its care model is designed to address physical and behavioral health needs in a coordinated setting, with an emphasis on chronic pain management, mental health, and substance-use treatment.

The company’s services include primary care, behavioral health support, treatment for opioid-use disorder and other addiction-related conditions, and care programs for patients dealing with chronic pain.